Binding sites for growth hormone-releasing peptide

Area of Science:

• Endocrinology
• Molecular Biology
• Cardiovascular Research

Background:

• Growth hormone-releasing peptides (GHRPs) stimulate growth hormone (GH) release via pituitary receptors.
• Evidence suggests multiple GHRP receptor subtypes may exist within the hypothalamic-pituitary system.
• Hexarelin, a potent GH secretagogue, has shown cardiac effects, implying myocardial GHRP binding sites.

Purpose of the Study:

• To investigate the presence and characteristics of GHRP receptors in both the anterior pituitary and myocardial tissues.
• To determine if distinct GHRP receptor subtypes are present in these different tissues.
• To develop a tool for specifically labeling and characterizing these potential receptors.

Main Methods:

• Development of a photoactivatable hexarelin derivative (Tyr-p-benzoyl phenylalanine-Ala-hexarelin).
• Specific labeling and characterization of GHRP receptors in anterior pituitary membranes (human, bovine, porcine) using the derivative.
• Demonstration of GHRP binding sites in myocardial tissue using the same photoactivatable approach.

Main Results:

• A putative GHRP receptor (approx. 57,000 Da) was identified and characterized in anterior pituitary membranes.
• The study confirmed the existence of GHRP binding sites within myocardial tissue.
• Differential binding affinities of GHRP analogues to cardiac tissue were observed.

Conclusions:

• Distinct GHRP receptor subtypes likely exist in the pituitary and cardiovascular systems.
• These findings suggest potential novel physiological roles for GHRPs beyond GH release.
• Further research is needed to elucidate the specific functions of these myocardial GHRP receptors.